Keep up with the exciting progress and milestones happening at Carcinotech.
Explore our library of case studies, application notes, and technical data to see how we can support your goals.
3D-printed tumours represent a significant advancement in cancer research, offering a more accurate and physiologically relevant model compared to traditional 2D cell cultures and animal models.
Over the past six years, Carcinotech has been laser-focused on developing, optimising and commercialising our innovative drug development platform .
A recent study conducted by Carcinotech, we explored whether a 3D-printed lung cancer model developed using our proprietary methodologies could serve as a valuable tool for pre-clinical research and drug development.
Cancer Research Horizons, the innovation arm of Cancer Research UK, announced the winners of its second Innovation & Entrepreneurship Awards at it’s gala dinner on the 20th of March in London.
